Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 9/20 | 0.40 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.39 |
| ▸ | CDK9 | P50750 | 1/20 | 0.39 |
| ▸ | HASPIN | Q8TF76 | 1/20 | 0.39 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.38 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1646345 | 0.81 | SCN9A (0.45) | — | |
| SCHEMBL29316090 | 0.79 | GABRP (0.44) | CCNT1CDK9HASPINIMPDH2 | |
| SCHEMBL29316086 | 0.76 | CCNT1 (0.42) | SLC6A4CCNT1CDK9HASPINSLC6A2 | |
| SCHEMBL29316102 | 0.75 | GABRP (0.40) | SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL29316076 | 0.74 | XDH (0.43) | — | |
| SCHEMBL1647154 | 0.72 | GABRA1 (0.43) | — | |
| SCHEMBL1646095 | 0.69 | ALDH1A1 (0.44) | — | |
| SCHEMBL11924851 | 0.68 | IMPDH2 (0.52) | SLC6A4CCNT1CDK9HASPINIMPDH2 | |
| SCHEMBL24214822 | 0.68 | GRM4 (0.42) | — | |
| SCHEMBL24214375 | 0.67 | PTGS2 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239768-A1 | METHOD FOR PREPARING XANTHINE OXIDASE INHIBITOR | LG CHEM, LTD. (KR) | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239768-A1 | METHOD FOR PREPARING XANTHINE OXIDASE INHIBITOR | XDH, AOX1, PNPO | SLC6A4 1663/4885CCNT1 1748/4885CDK9 1673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.